Raymond James Financial Services Advisors’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,050
| Closed | -$12.8K | – | 3258 |
|
2022
Q4 | $12.8K | Sell |
1,050
-37
| -3% | -$451 | ﹤0.01% | 3161 |
|
2022
Q3 | $9K | Buy |
+1,087
| New | +$9K | ﹤0.01% | 3184 |
|
2021
Q4 | – | Sell |
-1,133
| Closed | -$18K | – | 3251 |
|
2021
Q3 | $18K | Sell |
1,133
-12
| -1% | -$191 | ﹤0.01% | 3214 |
|
2021
Q2 | $106K | Buy |
1,145
+88
| +8% | +$8.15K | ﹤0.01% | 3120 |
|
2021
Q1 | $55K | Buy |
1,057
+152
| +17% | +$7.91K | ﹤0.01% | 3080 |
|
2020
Q4 | $24K | Hold |
905
| – | – | ﹤0.01% | 2922 |
|
2020
Q3 | $25K | Buy |
+905
| New | +$25K | ﹤0.01% | 2786 |
|